Free Trial

Shoulder Innovations, Inc. (NYSE:SI) Director Michael A. Carusi Buys 266,666 Shares

Shoulder Innovations logo with Medical background

Key Points

  • Director Michael A. Carusi of Shoulder Innovations Inc acquired 266,666 shares at $15.00 per share, totaling nearly $4 million and increasing his position by 16.48% to 1,885,136 shares.
  • The company's stock was down 0.6% during trading, with shares priced at $14.18, reflecting a market capitalization of approximately $448.92 million.
  • Shoulder Innovations specializes in medical technology focused on transforming shoulder surgical care with advanced implant systems.
  • Need better tools to track Shoulder Innovations? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) Director Michael A. Carusi acquired 266,666 shares of Shoulder Innovations stock in a transaction dated Friday, August 1st. The shares were purchased at an average cost of $15.00 per share, with a total value of $3,999,990.00. Following the completion of the transaction, the director directly owned 1,885,136 shares of the company's stock, valued at $28,277,040. This trade represents a 16.48% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shoulder Innovations Stock Up 1.3%

Shares of SI stock traded up $0.16 on Friday, hitting $12.32. 142,194 shares of the stock were exchanged, compared to its average volume of 597,503. Shoulder Innovations, Inc. has a fifty-two week low of $11.75 and a fifty-two week high of $17.94.

About Shoulder Innovations

(Get Free Report)

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

Further Reading

Should You Invest $1,000 in Shoulder Innovations Right Now?

Before you consider Shoulder Innovations, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.

While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines